June 15, 2015
- Department of Pathology
Dr. Cheryl Willman, Professor in the UNM Pathology Department, has been promoted to the rank of University Distinguished Professor. This accolade is the highest honor bestowed by the University of New Mexico to its faculty and is reserved for those individuals who are recognized nationally and internationally as intellectual leaders and who have made extraordinary accomplishments and contributions in their respective fields. Congratulations to Dr. Cheryl Willman on this prodigious achievement!
Dr. Willman received her medical degree from the Mayo Medical School in Rochester, Minn. and she completed an Anatomic Pathology Residency at UNM School of Medicine. She is an internationally recognized leukemia researcher; a founder of the first NCI TARGET Project to discover new therapeutic targets in high-risk acute lymphoblastic leukemia (ALL) in children and adults. As a result of this research, new therapeutic targets and diagnostics have come from this program. She has been the director and CEO of the UNM Cancer Center and has led the development of the clinical, research, education and community outreach programs at the center. This work aided in the formal designation of the center as a National Cancer Institute Designated Center in 2005 and as a Comprehensive Center in 2015. Dr. Willman has served on numerous committees such as Chair of the Leukemia Translational Medicine Subcommittee, Southwest Oncology Group, American Board of Pathology, Molecular Pathology Test Committee and Board of Directors, American Association of Cancer Institutes as well as many others.